Availability of nicotine replacement therapy in substance use disorder treatment: longitudinal patterns of adoption, sustainability, and discontinuation
- PMID: 21531090
- PMCID: PMC3150224
- DOI: 10.1016/j.drugalcdep.2011.03.028
Availability of nicotine replacement therapy in substance use disorder treatment: longitudinal patterns of adoption, sustainability, and discontinuation
Abstract
Background: There is growing recognition regarding the clinical importance of integrating smoking cessation services, such as nicotine replacement therapy (NRT), within programs that treat substance use disorders (SUDs) since the majority of individuals receiving treatment also smoke. Previous research has not examined the organizational characteristics associated with NRT availability over time in SUD treatment programs.
Method: Using longitudinal data collected from administrators of 868 SUD treatment programs over a four-year period, the availability of NRT in the forms of the nicotine patch or nicotine gum was measured. Associations between organizational covariates and NRT adoption were estimated using multinomial logistic regression.
Results: The rate of NRT availability significantly decreased over time from 38.0% of SUD programs at baseline to 33.8% at follow-up. The multinomial logistic regression model indicated programs that sustained adoption of NRT over time were more medically oriented, as measured by location in a hospital setting and access to physicians, and were less likely to offer outpatient services. Sustained and recent adopters of NRT were more likely to offer other smoking cessation interventions at follow- up than NRT discontinuers or NRT non-adopters.
Conclusions: These findings suggest that patients' access to NRT varies across different types of treatment organizations. Future research should continue to measure the availability of NRT and other smoking cessation interventions in SUD treatment since these services may help patients to quit smoking and reduce the likelihood of SUD relapse.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.Cochrane Database Syst Rev. 2019 Apr 18;4(4):CD013308. doi: 10.1002/14651858.CD013308. Cochrane Database Syst Rev. 2019. Update in: Cochrane Database Syst Rev. 2023 Jun 19;6:CD013308. doi: 10.1002/14651858.CD013308.pub2. PMID: 30997928 Free PMC article. Updated.
-
Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.BMC Med. 2016 Jun 7;14:80. doi: 10.1186/s12916-016-0626-2. BMC Med. 2016. PMID: 27233840 Free PMC article. Clinical Trial.
-
Use of nicotine replacement therapy for smoking reduction and during enforced temporary abstinence: a national survey of English smokers.Addiction. 2011 Jan;106(1):197-204. doi: 10.1111/j.1360-0443.2010.03215.x. Epub 2010 Nov 18. Addiction. 2011. PMID: 21083833
-
Characterization of long-term users of nicotine replacement therapy: evidence from a national survey.Nicotine Tob Res. 2014 Aug;16(8):1050-5. doi: 10.1093/ntr/ntu019. Epub 2014 Mar 7. Nicotine Tob Res. 2014. PMID: 24610398
-
Nicotine replacement therapy for long-term smoking cessation: a meta-analysis.Tob Control. 2006 Aug;15(4):280-5. doi: 10.1136/tc.2005.015487. Tob Control. 2006. PMID: 16885576 Free PMC article. Review.
Cited by
-
Characterizing smoking, cessation services, and quit interest across outpatient substance abuse treatment modalities.J Subst Abuse Treat. 2014 Feb;46(2):194-201. doi: 10.1016/j.jsat.2013.07.009. Epub 2013 Aug 27. J Subst Abuse Treat. 2014. PMID: 23988192 Free PMC article.
-
The prevalence and correlates of single cigarette selling among urban disadvantaged drug users in Baltimore, Maryland.Drug Alcohol Depend. 2013 Oct 1;132(3):466-70. doi: 10.1016/j.drugalcdep.2013.03.007. Epub 2013 Apr 8. Drug Alcohol Depend. 2013. PMID: 23578589 Free PMC article. Clinical Trial.
-
Cigarette Smoking During Substance Use Disorder Treatment: Secondary Outcomes from a National Drug Abuse Treatment Clinical Trials Network study.J Subst Abuse Treat. 2015 Jun;53:39-46. doi: 10.1016/j.jsat.2014.12.007. Epub 2014 Dec 30. J Subst Abuse Treat. 2015. PMID: 25595301 Free PMC article.
-
Achieving Smoking Cessation Among Persons with Opioid Use Disorder.CNS Drugs. 2020 Apr;34(4):367-387. doi: 10.1007/s40263-020-00701-z. CNS Drugs. 2020. PMID: 32107731 Free PMC article. Review.
-
Substance Use Disorder Counselors' Reports of Tobacco Cessation Services Availability, Implementation, and Tobacco-related Knowledge.J Adolesc Health. 2015 Sep;57(3):327-33. doi: 10.1016/j.jadohealth.2015.06.001. J Adolesc Health. 2015. PMID: 26299559 Free PMC article.
References
-
- Agboola S, McNeill A, Coleman T, Bee JL. A systematic review of the effectiveness of smoking relapse prevention interventions for abstinent smokers. Addiction. 2010;105:1362–1380. - PubMed
-
- Allison PD. Missing Data. Sage; Thousand Oaks, CA: 2002.
-
- Baca CT, Yahne CE. Smoking cessation during substance abuse treatment: what you need to know. J. Subst. Abuse Treat. 2009;36:205–219. - PubMed
-
- Barnard J, Rubin DR. Small sample degrees of freedom with multiple imputation. Biometrika. 1999;86:948–955.